000 01323 a2200385 4500
005 20250514220616.0
264 0 _c20050613
008 200506s 0 0 eng d
022 _a0007-0963
024 7 _a10.1111/j.1365-2133.2005.06326.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuilabert, A
245 0 0 _aPegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
_h[electronic resource]
260 _bThe British journal of dermatology
_cFeb 2005
300 _a377-9 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aAntiviral Agents
_xadverse effects
650 0 4 _aDrug Eruptions
_xetiology
650 0 4 _aEyelid Diseases
_xchemically induced
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadverse effects
650 0 4 _aMale
650 0 4 _aPolyethylene Glycols
650 0 4 _aRecombinant Proteins
650 0 4 _aSarcoidosis
_xchemically induced
700 1 _aBosch, X
700 1 _aJulià, M
700 1 _aIranzo, P
700 1 _aMascaró, J M
773 0 _tThe British journal of dermatology
_gvol. 152
_gno. 2
_gp. 377-9
856 4 0 _uhttps://doi.org/10.1111/j.1365-2133.2005.06326.x
_zAvailable from publisher's website
999 _c15402493
_d15402493